These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 25443648)
1. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer]. Garcia JR; Moreno C; Valls E; Cozar P; Bassa P; Soler M; Alvarez-Moro FJ; Moragas M; Riera E Rev Esp Med Nucl Imagen Mol; 2015; 34(3):155-61. PubMed ID: 25443648 [TBL] [Abstract][Full Text] [Related]
2. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265 [TBL] [Abstract][Full Text] [Related]
3. Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy. Fuccio C; Castellucci P; Schiavina R; Santi I; Allegri V; Pettinato V; Boschi S; Martorana G; Al-Nahhas A; Rubello D; Fanti S Ann Nucl Med; 2010 Jul; 24(6):485-92. PubMed ID: 20544323 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility and therapeutic impact of PET/CT [ Sánchez N; Valduvieco I; Ribal MJ; Campos F; Casas F; Nicolau C; Salvador R; Mellado B; Jorcano S; Fuster D; Paredes P Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):284-291. PubMed ID: 32467000 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of Kitajima K; Fukushima K; Yamamoto S; Kato T; Odawara S; Takaki H; Fujiwara M; Yamakado K; Nakanishi Y; Kanematsu A; Nojima M; Hirota S Nagoya J Med Sci; 2017 Aug; 79(3):387-399. PubMed ID: 28878443 [TBL] [Abstract][Full Text] [Related]
6. Value of García JR; Compte A; Buxeda M; Mourelo S; Soler M; Blanch A; Valls E; Riera E Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):197-203. PubMed ID: 32165153 [TBL] [Abstract][Full Text] [Related]
7. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related]
8. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial. Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562 [TBL] [Abstract][Full Text] [Related]
9. Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431 [TBL] [Abstract][Full Text] [Related]
10. Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy. Fuccio C; Castellucci P; Schiavina R; Guidalotti PL; Gavaruzzi G; Montini GC; Nanni C; Marzola MC; Rubello D; Fanti S Eur J Radiol; 2012 Aug; 81(8):e893-6. PubMed ID: 22621862 [TBL] [Abstract][Full Text] [Related]
11. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [TBL] [Abstract][Full Text] [Related]
12. [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. Picchio M; Spinapolice EG; Fallanca F; Crivellaro C; Giovacchini G; Gianolli L; Messa C Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):13-26. PubMed ID: 21932120 [TBL] [Abstract][Full Text] [Related]
13. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer]. García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948 [TBL] [Abstract][Full Text] [Related]
15. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262 [TBL] [Abstract][Full Text] [Related]
16. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy? Pietrzak AK; Czepczynski R; Wierzchoslawska E; Cholewinski W Urol J; 2018 Sep; 15(5):242-247. PubMed ID: 29681049 [TBL] [Abstract][Full Text] [Related]
17. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer. Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446 [TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330 [TBL] [Abstract][Full Text] [Related]
19. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer. Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557 [TBL] [Abstract][Full Text] [Related]
20. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Zhou J; Gou Z; Wu R; Yuan Y; Yu G; Zhao Y Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]